Department of Ophthalmology, University of Perugia, Perugia, Italy.
Clin Exp Ophthalmol. 2013 Sep-Oct;41(7):644-7. doi: 10.1111/ceo.12087. Epub 2013 Apr 11.
To compare penetration in the aqueous humour of topically applied antibiotics.
Randomized prospective study, Department of Ophthalmology, University of Perugia, Italy
Patients undergoing cataract surgery.
One hundred twenty-two patients were included: 14 received one drop of chloramphenicol suspension; 12 one application of chloramphenicol gel; 11 one drop of netilmicin suspension; 13 one drop of tobramycin suspension; 37 repeated instillations of chloramphenicol suspension every 10 min for a total of four drops; and 35 repeated instillations of chloramphenicol gel every 10 min for a total of four drops. Samples were taken immediately before surgery from the anterior chamber in order to determine the antibiotic by means of high-performance liquid chromatography. Samples were taken 45-190 min after the eye drops were instilled.
Intraocular penetration of chloramphenicol, netilmicin and tobramicyn.
After a single administration, netilmicin and tobramycin were undetectable, whereas the chloramphenicol suspension reached a mean concentration of 0.23 ± 0.21 μg/mL, and the chloramphenicol gel a mean concentration of 0.13 ± 0.14 μg/mL. After repeated administrations, the mean concentrations of the chloramphenicol suspension and gel were 0.60 ± 0.26 μg/mL and 0.58 ± 0.18 μg/mL, respectively.
Tobramycin and netilmicin do not reach detectable concentrations, whereas chloramphenicol, after multiple administrations, reaches concentrations that are effective against Haemophilus influenzae and Haemophilus parainfluenzae, Legionella pneumophila, Moraxella catarrhalis, Neisseria meningitidis, Pasteurella multocida and Streptococcus pneumoniae. This means that chloramphenicol can be rationally used in the prophylaxis and treatment of infections supported by sensitive germs.
比较局部应用抗生素在房水中的渗透。
意大利佩鲁贾大学眼科系的一项随机前瞻性研究。
接受白内障手术的患者。
共纳入 122 例患者:14 例接受氯霉素混悬液滴眼 1 滴;12 例应用氯霉素凝胶 1 次;11 例给予庆大霉素滴眼液滴眼 1 滴;13 例每 10 分钟滴氯霉素混悬液 4 滴,共 4 滴;35 例每 10 分钟滴氯霉素凝胶 4 滴,共 4 滴。手术前立即从前房取样本,用高效液相色谱法测定抗生素。滴眼后 45-190 分钟取样本。
氯霉素、庆大霉素和妥布霉素的眼内渗透。
单次给药后,庆大霉素和妥布霉素均无法检出,而氯霉素混悬液平均浓度为 0.23±0.21μg/mL,氯霉素凝胶平均浓度为 0.13±0.14μg/mL。反复给药后,氯霉素混悬液和凝胶的平均浓度分别为 0.60±0.26μg/mL和 0.58±0.18μg/mL。
妥布霉素和庆大霉素未达到可检出浓度,而氯霉素经多次给药后可达到有效抑制流感嗜血杆菌和副流感嗜血杆菌、嗜肺军团菌、卡他莫拉菌、脑膜炎奈瑟菌、多杀巴斯德菌和肺炎链球菌的浓度。这意味着氯霉素可以合理地用于支持敏感菌的感染预防和治疗。